米歇利奥利在骨髓增殖性瘤中通过通过对STAT3/5蛋白质的共价结合来抑制STAT3/5酸化而发挥作用
Huijun Huang1, Jinqin Liu1, Lin Yang1
1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
Blood science (Baltimore, Md.)
|November 9, 2023
概括
米歇利化物 (MCL) 通过准JAK/STAT信号,增强了ruxolitinib对髓增殖性瘤 (MPN) 的疗效. 这种组合疗法对单独使用鲁克索利提尼布的患者表现不佳的患者有希望.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 鲁克索利提尼布是治疗髓增殖性瘤 (MPNs) 的关键治疗方法.
- 有相当数量的MPN患者对ruxolitinib表现出不理想的反应.
- 需要新的治疗策略来改善这些患者的治疗结果.
研究的目的:
- 为了评估单独和与 ruxolitinib 结合使用的米歇里奥利 (MCL) 的疗效.
- 在MPN模型中研究MCL及其衍生物DMAMCL的治疗潜力.
- 为了阐明MCL在MPN治疗中的作用机制.
主要方法:
- 使用患者衍生的MPN样本,MPN细胞系和JAK2V617F敲入小鼠模型.
- 在体外测试评估了殖民地形成,细胞生长和存活率.
- 在体内研究中评估了脊髓巨变,细胞因子生产和突变性等位基因负担.
- 机理学研究重点是STAT3/5酸化和JAK/STAT信号抑制.
主要成果:
- MCL抑制了造血原始细胞殖民地形成和MPN细胞生长/存活.
- 与MCL和鲁克索利提尼布的联合治疗显示,与单独使用鲁克索利提尼布相比,它具有更强的抑制作用.
- 在DMAMCL增强了ruxolitinib在减少小鼠缩和细胞因子水平的有效性,而不会影响正常的血液形成.
- MCL针对JAK2V617F克隆,减少突变的等位基因负担,并通过对STAT3/5.5进行共价结合来抑制JAK/STAT信号传递.
结论:
- 米歇利化物 (MCL) 显示出单独和与ruxolitinib.com结合的显著抗MPN活性.
- 结合MCL和ruxolitinib为MPN患者提供了一个有前途的治疗方法,患者的反应不足最佳.
- 由于MCL能够向JAK2V617F克隆并抑制JAK/STAT信号传递,因此需要进一步的临床研究.
相关概念视频
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Drugs that Destabilize Microtubules
2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K


